XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.06

+0.3%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WL who wrote (3880)	9/24/1997 1:43:00 AM
From: aknahow	of 17367

WL, admit this is based just on t following thoughts not knowledge of hw the trials really work. To me each disease can probably impact the health of a patient differently. What is a safe drug or dose in one disease might be unsafe in another. Example, asprin for pre teens when they have flu like symptoms. So for CF with lungs filing with fluid seems logical to once again demonstrate BPI is safe. Now with safety test for any new drug it seems logical to start with a handful. You can't run a test on 10,000 to see if somehing is safe! What I think XOMA will clear up is that this is not a Phase one trial. It may be but they seemed very exact with their wording and until they say it was a phase one trial I guess I will have doubts. Yes I know I asked if people really knew if it was. It's just after seeing the answers I just don't feel convinced. Does not bother me that it might not be a phase one trial yet.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next